AH-7921 is an opioid analgesic drug selective for the µ-opioid receptor, having around 80% the potency of morphine when administered orally. It was made a Prohibited Substance in Australia in May 2014. AH-7921 has been illegal to distribute in Israel since December 2013. In the UK, AH-7921 was included as a Class A drug in January 2015 as part of The Misuse of Drugs Act 1971 (Amendment) (No. 2) Order 2014. In Brazil, AH-7921 has been an illegal drug since May 2015. As of October 2015, AH-7921 is a controlled substance in China. AH-7921 is banned in the Czech Republic. In the United States, AH-7921 was placed into Schedule I of the Controlled Substances Act on May 16, 2016. The Canadian Controlled Drugs and Substances Act was amended in 2016 to include the substance as a Schedule I substance. Possession without legal authority can result in maximum 7 years imprisonment. Further, Health Canada amended the Food and Drug Regulations in May 2016 to classify AH-7921 as a restricted drug. Only those with a law enforcement agency, a person with an exemption permit or institutions with Minister’s authorization may possess the drug in Canada.
Product Number: AHE10187
|Analyte||LOD||Matrices||Compounds||Cross Reactivity %|
|AH-7921||0.53 ng/mL||Whole Blood, Post Mortem Blood, Urine||AH-7921||100|